FDA greenlights COVID-19 booster vaccine for some immunocompromised patients
The U.S. Food and Drug Administration expanded emergency use of Pfizer-BioNTech and Moderna’s infectious-disease infectious-diseaseto authorize a booster shot for certain immunocompromised patients. HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise about 2.7% of the U.S. adult population. infectious-disease Growing evidence had suggested select immunocompromised patients mount a diminished protective…